Ned David

Ned David, co-founder of Unity Biotechnology and a PhD from Cal Berkeley, dives deep into the science of cellular senescence and its impact on aging. He explains how senolytic medicines could potentially treat age-related diseases like cancer and cardiovascular issues by targeting and eliminating senescent cells. Ned also shares insights on navigating biotechnology entrepreneurship, emphasizing the importance of calculated risks and innovative thinking in transforming ideas into successful companies.